Skip to content
GenoLensGenoLens

DPH1

Chr 17p13.3

diphthamide biosynthesis 1

Aliases:
OVCA1
MANE:
ENST00000263083.12

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Rare syndromic craniosynostosis or isolated multisuture synostosis

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • developmental delay with short stature, dysmorphic facial features, and sparse hair 1

    0.78
  • developmental delay with short stature, dysmorphic facial features, and sparse hair

    0.64
  • neurodegenerative disease

    0.49
  • hereditary disease

    0.34
  • Global developmental delay

    0.26
  • Hydrocephalus

    0.26
  • Dandy-Walker syndrome

    0.26
  • Cerebellar vermis hypoplasia

    0.26
  • intracerebral hemorrhage

    0.22
  • arthritic joint disease

    0.16

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

2-(3-amino-3-carboxypropyl)histidine synthase subunit 1

Catalyzes the first step of diphthamide biosynthesis, a post-translational modification of histidine which occurs in elongation factor 2 (PubMed:30877278). DPH1 and DPH2 transfer a 3-amino-3-carboxypropyl (ACP) group from S-adenosyl-L-methionine (SAM) to a histidine residue, the reaction is assisted by a reduction system comprising DPH3 and a NADH-dependent reductase (By similarity). Acts as a tumor suppressor (PubMed:10519411)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.